ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

April 30, 2010

Conditions

Male Breast CancerRecurrent Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast Cancer

Interventions

BIOLOGICAL

ONTAK

Given IV

OTHER

flow cytometry

Correlative studies

OTHER

immunohistochemistry staining method

Correlative studies

OTHER

enzyme-linked immunosorbent assay

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

GENETIC

protein expression analysis

Correlative studies

Trial Locations (1)

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT00425672 - ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment | Biotech Hunter | Biotech Hunter